Researchers from Touro University and Lovelace Biomedical are Developing an Innovative Treatment for Lung Cancer ...

New research delves into the DNA details and chromatin structures that may predict prognosis in early-stage lung ...

Life expectancy for people with metastatic or metastasized lung cancer is low. The 5-year survival rate for small cell lung cancer is 3%, and 8% for non-small cell lung cancer (NSCLC). 25-30% of ...

Obesity is associated with an increased risk of developing breast cancer, and a greater probability for the cancer to spread ...

Obesity promotes BC metastasis by a neutrophil-dependent mechanism that induces vascular dysfunction, thereby allowing tumor cells to migrate to the lungs through the vascular endothelium.

In this case, it was the lungs that were being primed by tumors residing elsewhere. And much as Vander Heiden observed with breast cancer metastasis to the brain, access to fatty acids was a key ...

The results of the study, which used organoids derived from embryonic lungs, open up new perspectives ... Oct. 9, 2024 — Researchers have demonstrated that patients with metastatic non-squamous ...

First-line Rybrevant plus Lazcluze significantly extended overall survival versus Tagrisso in mutated, advanced or metastatic non-small cell lung cancer.

The latest data from Johnson and Johnson's Rybrevant and Lazcluze lung cancer combo was better than standard of care Tagrisso ...

CNIO researchers discover that, in mice that eat a lot of fat, cancer cells travelling through the blood surround themselves with platelets, which act as an armor-like protection as they spread. In ...